Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Tesla
TSLA
|
+$875M |
| 2 |
Advanced Micro Devices
AMD
|
+$777M |
| 3 |
Home Depot
HD
|
+$564M |
| 4 |
Meta Platforms (Facebook)
META
|
+$505M |
| 5 |
Merck
MRK
|
+$403M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$445M |
| 3 |
Chevron
CVX
|
+$395M |
| 4 |
Micron Technology
MU
|
+$379M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| 1 | Healthcare | 18.68% |
| 2 | Technology | 14.97% |
| 3 | Consumer Discretionary | 11.35% |
| 4 | Consumer Staples | 10.73% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3126
ProQR Therapeutics
PRQR
$231M
| $547K | ﹤0.01% |
+604,181
| New | +$547K |
|
3127
Paymentus
PAY
$4.1B
| $546K | ﹤0.01% |
+25,900
| New | +$546K |
|
|
PPTA
3128
Perpetua Resources
PPTA
$1.86B
| $546K | ﹤0.01% |
133,100
+110,300
| +484% | +$452K |
|
3129
Vanguard Small-Cap Value ETF
VBR
$31.6B
| $545K | ﹤0.01% |
3,100
-1,700
| -35% | -$299K |
|
3130
Moog Class B
MOG.B
| $545K | ﹤0.01% |
6,100
| – | – |
|
3131
Globus Maritime Ltd
GLBS
$21.6M
| $544K | ﹤0.01% |
235,499
+207,259
| +734% | +$479K |
|
|
CYXT
3132
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
| $544K | ﹤0.01% |
+44,500
| New | +$544K |
|
3133
Nerdy
NRDY
$158M
| $542K | ﹤0.01% |
106,500
+75,300
| +241% | +$383K |
|
3134
Caledonia Mining Corp
CMCL
$639M
| $541K | ﹤0.01% |
35,565
+5,065
| +17% | +$77K |
|
|
MTL.PR
3135
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
| $541K | ﹤0.01% |
898,438
-51,500
| -5% | -$31K |
|
3136
Allegro MicroSystems
ALGM
$5.51B
| $540K | ﹤0.01% |
+19,000
| New | +$540K |
|
3137
Nomura Holdings
NMR
$22B
| $539K | ﹤0.01% |
127,690
-74,600
| -37% | -$315K |
|
|
EXK
3138
Endeavour Silver
EXK
$1.78B
| $538K | ﹤0.01% |
115,800
-249,700
| -68% | -$1.16M |
|
|
ONL
3139
Orion Office REIT
ONL
$168M
| $538K | ﹤0.01% |
+38,400
| New | +$538K |
|
3140
GT Biopharma
GTBP
$2.86M
| $537K | ﹤0.01% |
6,210
-4,013
| -39% | -$347K |
|
|
NEXN
3141
Nexxen International
NEXN
$618M
| $537K | ﹤0.01% |
35,300
-26,000
| -42% | -$396K |
|
3142
Cadiz
CDZI
$322M
| $536K | ﹤0.01% |
+258,900
| New | +$536K |
|
|
CBIO
3143
Crescent Biopharma, Inc. Common Stock
CBIO
$174M
| $536K | ﹤0.01% |
4,706
-1,307
| -22% | -$149K |
|
3144
Kopin
KOPN
$412M
| $536K | ﹤0.01% |
211,964
-10,800
| -5% | -$27.3K |
|
3145
VirTra
VTSI
$62.9M
| $536K | ﹤0.01% |
87,800
-23,100
| -21% | -$141K |
|
|
DMTK
3146
DELISTED
DermTech, Inc. Common Stock
DMTK
| $536K | ﹤0.01% |
+36,500
| New | +$536K |
|
|
ARAV
3147
DELISTED
Aravive, Inc. Common Stock
ARAV
| $536K | ﹤0.01% |
277,829
-64,500
| -19% | -$124K |
|
|
CLEU
3148
DELISTED
China Liberal Education Holdings
CLEU
| $534K | ﹤0.01% |
+21
| New | +$534K |
|
|
LND
3149
BrasilAgro
LND
$377M
| $533K | ﹤0.01% |
78,900
+48,100
| +156% | +$325K |
|
3150
Generation Bio
GBIO
$39.9M
| $532K | ﹤0.01% |
7,250
-15,640
| -68% | -$1.15M |
|